MedPath

Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: lotrafilcon B, BC 8.60
Device: comfilcon A, BC 8.60
Device: galyfilcon A, BC 8.30
Registration Number
NCT01244516
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

The purpose of this study is to compare the clinical performance of three silicone hydrogel contact lenses over a 2 week period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
540
Inclusion Criteria
  • Be no less than 18 and no more than 39 years of age.
  • Sign Written Informed Consent and investigator to record this on Case Report Form.
  • Be willing and able to adhere to the instructions set out in the protocol.
  • Be an existing successful daily wear soft contact lens wearer. For the purposes of this study this means wearing lenses for at least 6 hours per day, 5 days per week for the last month.
  • No extended wear in the last 3 months.
  • Subjective refraction must result in a vertex corrected spherical contact lens prescription between -1.00 and -6.00 diopters.
  • Have refractive astigmatism less than or equal to 1.00 diopters (D) in both eyes.
  • Achieve visual acuity of 6/9 (20/30) or better in each eye.
  • Require a visual correction in both eyes (no monovision allowed).
  • Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: no amblyopia, no evidence of lid abnormality or infection (including blepharitis/meibomitis), no conjunctival abnormality or infection, no clinically significant slit lamp findings (i.e. stromal edema, vascularization, infiltrates or abnormal opacities), no other active ocular disease.
Exclusion Criteria
  • Requires concurrent ocular medication.
  • Clinically significant corneal stromal haze, corneal vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  • Clinically significant corneal staining
  • Requires presbyopic correction (i.e. Not using any presbyopic correction and measured add power of less than +1.00 diopters).
  • Has had refractive surgery.
  • Has had eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
  • Abnormal lacrimal secretions.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Keratoconus or other corneal irregularity.
  • Hard, hybrid or Rigid Gas Permeable lens wear in the previous 8 weeks.
  • Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  • Diabetic.
  • Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease [e.g., Human immunodeficiency virus (HIV)].
  • History of chronic eye disease (e.g. glaucoma or Age Related Macular Degeneration).
  • Pregnancy, lactating or planning a pregnancy at the time of enrollment.
  • Participation in any concurrent clinical trial or in last 30 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
lotrafilcon Blotrafilcon B, BC 8.60Subjects that were randomized to wear lotrafilcon B lens throughout the course of the study.
comfilcon Acomfilcon A, BC 8.60Subjects that were randomized to wear comfilcon A lens throughout the course of the study.
galyfilcon Agalyfilcon A, BC 8.30Subjects that were randomized to receive the galyfilcon A lens with a base curve of 8.30 throughout the entire course of the study.
Primary Outcome Measures
NameTimeMethod
Overall Subjective Comfortafter 2 weeks of contact lens wear

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.

Corneal Stainingafter 2 weeks of contact lens wear

Investigator evaluated corneal staining. Percent of eyes with corneal staining presence or absence is evaluated.

Secondary Outcome Measures
NameTimeMethod
Overall Subjective Lens Handlingafter 2 weeks of contact lens wear

Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0 to 120. Only galyficlon A and comfilcon A were evaluated.

© Copyright 2025. All Rights Reserved by MedPath